Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date  ▴ Location
Stopping Alzheimer’s Cold: Satori Raises $22M to Pursue Its Vision Luke Timmerman 01/08/09 Boston
3Tier Group Gets $10M, Socialmedian Sold for $7.5M, Gates Gives $7M to IDRI, & More Seattle-Area Deals News Gregory T. Huang 12/23/08 Seattle
Cadence Turns Attention to Marketplace, as IV Pain Reliever Reaches Goals in Clinical Trials Luke Timmerman 12/18/08 San Diego
Vaccines Force Their Way off Pharma’s Back Burner, as Price Increases Help Fuel New Wave of Innovation Luke Timmerman 12/12/08 Seattle
Ambrx Aims to Create New Breed of Custom-Built Biotech Drugs Luke Timmerman 12/08/08 San Diego
Out With the Old Shots, In With the New: Xconomy Forum To Explore Disruptive Changes in Vaccines Luke Timmerman 12/05/08 Seattle
Optimer Sharpens Up Commercial Game Plan, After “C.Diff” Drug Success Luke Timmerman 12/05/08 San Diego
Boston Biotechs Seek Scarce Funds Amid Market Famine at Annual Pitch Event Ryan McBride 12/04/08 Boston
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Seattle-Area Life Sciences News Luke Timmerman 12/04/08 Seattle
The Pros (and Not Many Cons) of Merck’s HPV Vaccine, According to UW’s Laura Koutsky Luke Timmerman 12/03/08 Seattle
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News Rebecca Zacks 11/24/08 Boston
Idera and Merck Extend R&D Deal Ryan McBride 11/20/08 Boston
Seattle’s Pharma Godfather, Vaccine Impresario Re-Emerges, Accelerator Gets New Investor & More Seattle-Area Life Sciences News Luke Timmerman 11/20/08 Seattle
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacks Luke Timmerman 11/17/08 Seattle
Simple DNA Test Spots Deadly MRSA Bacteria; Adnavance Aims To Take It Mainstream Luke Timmerman 11/10/08 San Diego
Illumina Shows its Stuff to Wall Street, Stock Still Slides Luke Timmerman 11/07/08 San Diego
Sirtris Shifts Focus From Resveratrol, Merck Shifts People From Seattle to Boston, Epix Shifts Into Cost-Saving Mode, & More Boston-Area Life Sciences News Rebecca Zacks 10/29/08 Boston
Gov. Gregoire Urges Biotechies to “Stay Focused”; UW Makes its Biotech Business Case, And A Host of Startups Debut Luke Timmerman 10/28/08 Seattle
Merck Shutdown of Rosetta is Seattle’s Loss, Boston’s Gain As Company Tries to Lure Key Researchers East Luke Timmerman 10/24/08 Seattle
Merck Bails on Seattle, Gates Foundation Backs Far-Out Ideas, Zymo Drug Shows Promise & More Seattle-Area Life Sciences News Luke Timmerman 10/23/08 Seattle
Vulcan’s Healey “Disappointed” in Merck Shutdown, But Says Other Tenants May Fill Void Luke Timmerman 10/22/08 Seattle
Merck Closing Seattle’s Rosetta Research Center, Cutting 300 Jobs Luke Timmerman 10/22/08 Seattle
Neuroptix Raises $18.5M For Alzheimer’s Diagnostic Test Luke Timmerman 10/22/08 Boston
Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News Rebecca Zacks 10/22/08 Boston
Ariad Gets $12.5M From Merck For Beginning Cancer Trial Luke Timmerman 10/20/08 Boston
Archemix Looks to Hitch Eli Lilly to Aptamer Express in New Deal Ryan McBride 10/20/08 Boston
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV Luke Timmerman 10/14/08 Boston
Lilly Patches Up Relationships in Seattle Biotech, Pushes TB Drug Discovery Luke Timmerman 10/07/08 Seattle
Amgen’s Dmab Cuts Fracture Risk for Osteoporosis Patients, Just What Investors Wanted to See Luke Timmerman 09/16/08 Seattle
Novartis To Beef Up Vaccine Research in Cambridge Luke Timmerman 09/12/08 Boston
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.